Allergan spins off AMO
This article was originally published in The Gray Sheet
Executive Summary
Advanced Medical Optics ophthalmic surgical and contact lens care businesses are spun-off July 1 via tax-free dividend to shareholders, with one AMO share distributed for every 4.5 Allergan shares held. Plans for the move were first announced in January (1"The Gray Sheet" Jan. 28, 2002, p. 11). AMO, which generates about $500 mil. in revenues, will move to Santa Ana, California from Irvine on Aug. 1. Allergan says that the spin-off will allow the firm to focus on its core pharmaceuticals business...
You may also be interested in...
AMO Surgical Devices Outshine Lens Care Products In First Earnings Report
Advanced Medical Optics' sales of intraocular lenses and phacoemulsification devices supported an 8.2% increase in ophthalmic surgical device revenue in the second quarter - the period just prior to AMO's June 29 spin-off from Allergan
Allergan Ophthalmic Products Spin-Off Creates $500 Mil. Device Company
Advanced Medical Optics' plan to develop a phakic intraocular lens (IOL) based on Ophtec BV's Artisan lens technology exemplifies the types of strategic alliance to be highlighted by AMO following its spin-off from Allergan in July
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”